By using an imaging pipeline of MRI, μCT, and EM, Foxley, Kasthuri, and their team were able to simultaneously resolve brain structures, like the white matter, at (a) macro-, (b) meso-, and (c) microscopic-scales in the same brain. Image from Foxley et al. July 2, 2021 — Researchers at the University of Chicago and the U.S. Department of Energy's (DOE) Argonne National Laboratory have leveraged existing advanced X-ray microscopy techniques to bridge the gap between MRI (magnetic resonance imaging) and electron microscopy imaging, providing a viable pipeline for multiscale whole ..read more

Native Sponsored Content:  0 ..read more

This is Figure 2 from the article in Radiology: Acute encephalopathy. A 60 year-old-man without history of seizures presenting with convulsion. (A-B) Multifocal areas of FLAIR hyperintensity in the right cerebellum (arrows in A), left anterior cingular cortex and superior frontal gyrus (arrows in B). (C-D) Restricted diffusion in the left anterior cingulate cortex, superior frontal and middle temporal gyrus (arrows in D) and right cerebellum (arrows in E), consistent with cerebellar diaschisis. F) No hemosiderin deposits in gradient echo sequences. June 2, 2020 — Four recent radiology stu ..read more

Feinstein Institutes' Thomas Chaly, Ph.D., in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s December 26, 2019 — The Feinstein Institutes for Medical Research has received U.S. Food and Drug Administration (FDA) approval for a new positron emission tomography (PET) drug to combat Parkinson’s disease. Fluorodopa F-18 (FDOPA) Injection (NDA 200655) will help visualize dopaminergic nerve terminals in the striatum for the evaluation of patients with suspected Parkinsonian synd ..read more

November 28, 2019 — Individuals with functional neurological disorder (FND) have symptoms not explained by traditional neurological conditions, including limb weakness, tremor, gait abnormalities, seizures and sensory deficits. New research led by investigators at Massachusetts General Hospital (MGH) and published in Psychological Medicine has uncovered pathways in the brain's white matter that may be altered in patients with FND. The findings advance current understanding of the mechanisms involved in this disease, and offer the possibility of identifying markers of the condition and patien ..read more

The Neuroreader software program quantifies brain volume in study participants with TBI. Image courtesy of UCLA Health. October 29, 2019 — A UCLA-led study finds that, with the use of magnetic resonance imaging (MRI) scans, it is possible to distinguish between memory loss caused by Alzheimer’s disease and traumatic brain injury. Researchers from UCLA, along with colleagues at Washington University in St. Louis, say the finding is important because it could help prevent a misdiagnosis of Alzheimer’s disease, which can be devastating for patients and their families. One study found that ..read more

Image courtesy of NVIDIA October 23, 2019 — To help advance medical research while preserving data privacy and improving patient outcomes for brain tumor identification, NVIDIA researchers in collaboration with King’s College London researchers recently announced the introduction of the first privacy-preserving federated learning system for medical image analysis. NVIDIA is working with King’s College London and French startup Owkin to enable federated learning for the newly established London Medical Imaging and AI Centre for Value Based Healthcare. This new paper was presented at the ..read more

October 16, 2019 — Guerbet announced it has signed an exclusive agreement with Icometrix for the distribution in France, Italy and Brazil of icobrain, their software-as-a-service (SaaS) artificial intelligence (AI)-based medical imaging solution. Icobrain is designed to help radiologists and neurologists diagnose and monitor patients with neurological disorders. The AI software extracts clinically meaningful information from brain computed tomography (CT) or magnetic resonance imaging (MRI) scans of patients with multiple sclerosis, dementia or brain injury. Icobrain can therefore be used to ..read more

October 8, 2019 — The Radiological Society of North America (RSNA) recently launched its third annual artificial intelligence (AI) challenge: the RSNA Intracranial Hemorrhage Detection and Classification Challenge. The AI Challenge is a competition among researchers to create applications that perform a defined task according to specified performance measures. Last year’s pneumonia detection challenge had more than 1,400 teams. “The goal of an AI challenge is to explore and demonstrate the ways AI can benefit radiology and improve clinical diagnostics,” said Luciano Prevedello, M.D., MPH, ch ..read more

September 9, 2019 — Imaging Biometrics LLC (IB), in collaboration with the Medical College of Wisconsin (MCW), has received a $2.75 million, five-year grant award from the National Institutes of Health(NIH) - National Cancer Institute (NCI). Principal investigator Kathleen Schmainda, Ph.D., MCW professor of biophysics, will leverage her foundational work in perfusion magnetic resonance imaging (MRI) technologies to more precisely identify brain tumor burden and provide earlier treatment response assessment over what is currently available. The grant’s objectives also include incorporating ar ..read more